Contact
searchSearch
HMP Global

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

May 2014 - FRMC

Healthcare Costs Associated with Diagnosed Opioid Abuse
05/21/2014
Tampa—The National Survey on Drug Use and Health estimated that 2.1 million Americans ≥12 years of age had prescription pain reliever abuse or dependence in 2012. Prescription opioid abuse leads to significant economic and healthcare costs,...
Tampa—The National Survey on Drug Use and Health estimated that 2.1 million Americans ≥12 years of age had prescription pain reliever abuse or dependence in 2012. Prescription opioid abuse leads to significant economic and healthcare costs,...
Tampa—The National Survey on...
05/21/2014
First Report Managed Care
Comparison of Diabetes Treatment with DPP-4 Inhibitor or Sulfonylurea
05/21/2014
Tampa—Diabetes is associated with a sizeable national economic burden. In 2012 dollars, the burden of diagnosed cases in the United States was estimated at $245 billion. Patients with type 2 diabetes mellitus (T2DM)—accounting for 90% to 95%...
Tampa—Diabetes is associated with a sizeable national economic burden. In 2012 dollars, the burden of diagnosed cases in the United States was estimated at $245 billion. Patients with type 2 diabetes mellitus (T2DM)—accounting for 90% to 95%...
Tampa—Diabetes is associated...
05/21/2014
First Report Managed Care
Importance of Adherence and Quality Measures for RA
05/21/2014
Tampa—With the recent FDA approvals of new drugs to treat rheumatoid arthritis (RA) and updated guidelines, healthcare professionals have more information than ever about the disease. Still, speakers at a satellite symposium at the AMCP...
Tampa—With the recent FDA approvals of new drugs to treat rheumatoid arthritis (RA) and updated guidelines, healthcare professionals have more information than ever about the disease. Still, speakers at a satellite symposium at the AMCP...
Tampa—With the recent FDA...
05/21/2014
First Report Managed Care
Payer Knowledge on Oncology Biomarkers
05/21/2014
Tampa—Biomarkers have become an important part of individualized care and targeted therapies. Specifically for oncology, more targeted therapies are receiving FDA approval, with a focus on finding oncology biomarkers that will predict risk,...
Tampa—Biomarkers have become an important part of individualized care and targeted therapies. Specifically for oncology, more targeted therapies are receiving FDA approval, with a focus on finding oncology biomarkers that will predict risk,...
Tampa—Biomarkers have become an...
05/21/2014
First Report Managed Care
Response to Initial Biologic Therapy in IBD
05/21/2014
Tampa—Biologics are regularly used to treat different forms of inflammatory bowel disease (IBD). The most common types of IBD are Crohn’s disease and ulcerative colitis. However, biologic therapies used for IBD cost an estimated $15,000 to...
Tampa—Biologics are regularly used to treat different forms of inflammatory bowel disease (IBD). The most common types of IBD are Crohn’s disease and ulcerative colitis. However, biologic therapies used for IBD cost an estimated $15,000 to...
Tampa—Biologics are regularly...
05/21/2014
First Report Managed Care
A Robust Specialty Pipeline for Chronic and Orphan Diseases
05/21/2014
Tampa—The specialty pharmacy market is going to see increased competition and a number of orphan drug and breakthrough therapy approvals in the near future, according to Aimee Tharaldson, PharmD, senior clinic consultant, emerging...
Tampa—The specialty pharmacy market is going to see increased competition and a number of orphan drug and breakthrough therapy approvals in the near future, according to Aimee Tharaldson, PharmD, senior clinic consultant, emerging...
Tampa—The specialty pharmacy...
05/21/2014
First Report Managed Care
Rapid Learning Systems for Streamlined Care
05/21/2014
Tampa—To decrease costs and increase quality of care, the way healthcare providers exchange information and make treatment decisions, must be integrated and provide recommendations. According to Dr. Edward Li, PharmD, BCOP, associate...
Tampa—To decrease costs and increase quality of care, the way healthcare providers exchange information and make treatment decisions, must be integrated and provide recommendations. According to Dr. Edward Li, PharmD, BCOP, associate...
Tampa—To decrease costs and...
05/21/2014
First Report Managed Care

News

News
Assessing New Treatment Options for MS
05/21/2014
Since 2010, the FDA has approved 3 oral drugs—fingolimod, teriflunomide, and dimethyl fumarate—to treat patients with multiple sclerosis (MS).
Since 2010, the FDA has approved 3 oral drugs—fingolimod, teriflunomide, and dimethyl fumarate—to treat patients with multiple sclerosis (MS).
Since 2010, the FDA has approved...
05/21/2014
First Report Managed Care

Department

News Connection
Outcomes Data for Reimbursement
05/21/2014
Tampa—Despite the difficulties pharmaceutical manufacturers face in getting drugs approved, the FDA does not require them to submit outcomes data. During a session at the AMCP meeting, 2 speakers mentioned that information could be helpful in...
Tampa—Despite the difficulties pharmaceutical manufacturers face in getting drugs approved, the FDA does not require them to submit outcomes data. During a session at the AMCP meeting, 2 speakers mentioned that information could be helpful in...
Tampa—Despite the difficulties...
05/21/2014
First Report Managed Care
Conference Insider
The Challenges of Migrating the Previously Uninsured into New Insurance Venues
05/21/2014
Tampa—Managing the movement of the estimated 47 million to 50 million uninsured Americans into new insurance venues was the topic of a roundtable discussion led by Joe deSimone, research director, Health Strategies Group, during a session at...
Tampa—Managing the movement of the estimated 47 million to 50 million uninsured Americans into new insurance venues was the topic of a roundtable discussion led by Joe deSimone, research director, Health Strategies Group, during a session at...
Tampa—Managing the movement of...
05/21/2014
First Report Managed Care

Advertisement

Advertisement

Advertisement

FRMC Volume 21, Issue 3

Current Issue

September 2024
Volume 21
Issue 3
Current Issue
Issue Archive

Advertisement

Advertisement

What's Trending?

News
Most Effective Complementary, Alternative Medicine for Psoriasis
11/12/2018
Researchers recently examined complementary and alternative medicine therapies for the treatment of plaque psoriasis and identified the most effective treatments.
Researchers recently examined complementary and alternative medicine therapies for the treatment of plaque psoriasis and identified the most effective treatments.
Researchers recently examined...
11/12/2018
First Report Managed Care
News
House OK’s bill making insurers pay for autism services
07/29/2010
07/29/2010
First Report Managed Care
News Connection
Access to Multiple Health Systems May Put Patients at Risk
12/19/2016
The safety of patients with dementia who received prescriptions through both the Veterans Affairs system and through Medicare Part D was compromised. 
The safety of patients with dementia who received prescriptions through both the Veterans Affairs system and through Medicare Part D was compromised. 
The safety of patients with...
12/19/2016
First Report Managed Care
News
Lower Medicaid Dispensing Fees May Pressure Pharmacies
12/06/2011
12/06/2011
First Report Managed Care
News
Stem Cells Offer Promising Key to New Malaria Drugs - US Research
02/13/2015
Human stem cells engineered to produce renewable sources of mature, liver-like cells can be grown and infected with malaria to test potentially life-saving new drugs.
Human stem cells engineered to produce renewable sources of mature, liver-like cells can be grown and infected with malaria to test potentially life-saving new drugs.
Human stem cells engineered to...
02/13/2015
First Report Managed Care

Video Insights

Videos
Bridging the Gaps in Prior Authorization: Challenges, Solutions, and Collaboration for Better Patient Care
11/13/2024
David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...
David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...
David Sand, MD, MBA, chief...
11/13/2024
First Report Managed Care
Richard Lipton, MD
Videos
The Evolving Role of CGRP-targeting Therapies in Migraine Prevention
10/31/2024
Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.
Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.
Richard Lipton, MD, provides...
10/31/2024
First Report Managed Care
Alexander Spira, MD, PhD
Videos
Unmet Needs in the Treatment and Management of Non–Small Cell Lung Cancer
09/26/2024
Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).
Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).
Alexander I. Spira, MD, PhD,...
09/26/2024
First Report Managed Care
Videos
Treatment Options for NSCLC: A Discussion on Coverage, Clinical Outcomes, and Payer Perspectives
09/25/2024
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Learn about research...
09/25/2024
First Report Managed Care
Title Card
Videos
Addressing the Root Cause of a Common Ocular Condition: A Virtual Roundtable
09/04/2024
View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.
View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.
View a roundtable discussion on...
09/04/2024
First Report Managed Care
Jordan Bazinsky
Videos
Addressing Health Disparities and Promoting Equity: The Role of Advanced Imaging Solutions
08/15/2024
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Guest expert Jordan Bazinsky...
08/15/2024
First Report Managed Care
Farrukh Awan, MD
Videos
Promising Therapies and Clinical Trials for Chronic Lymphocytic Leukemia
08/14/2024
Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).
Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).
Farrukh Awan, MD, highlights...
08/14/2024
Journal of Clinical Pathways
Hayward
Videos
Evolving Health Care Contact Centers Into Drivers of Value-Based Care
07/31/2024
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact...
07/31/2024
First Report Managed Care
Lucille Accetta Headshot
Videos
Enhancing Patient Medication Adherence: Insights and Strategies From Asembia 2024
06/11/2024
Lucille Accetta, PharmD, MBA, MSPH, Senior Vice President of CVS Specialty Operations
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health...
06/11/2024
First Report Managed Care
Melissa Andel, Principal, CommonHealth Solutions, LLC
Videos
Navigating the Impact of the Inflation Reduction Act: Implications for Payers, Patients, and Manufacturers
05/24/2024
Melissa Andel, Principal, CommonHealth Solutions, LLC
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the...
05/24/2024
First Report Managed Care

Subscribe to our eNewsletters!

First Report Managed Care Newsletter

May 2014 Volume 11 Issue 5

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement